nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Ceruletide—CCKAR—type 2 diabetes mellitus	0.0171	1	CrCbGaD
Goserelin—LHCGR—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000415	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000415	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000412	0.00137	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.00041	0.00136	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000409	0.00136	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000407	0.00136	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000406	0.00135	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000404	0.00135	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000403	0.00134	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.0004	0.00133	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.0004	0.00133	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000399	0.00133	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000398	0.00133	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000393	0.00131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000391	0.0013	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.00039	0.0013	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000387	0.00129	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.00038	0.00127	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.00037	0.00123	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000366	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000366	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000364	0.00121	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000357	0.00119	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000356	0.00118	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000353	0.00118	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000351	0.00117	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000351	0.00117	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.00035	0.00117	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000349	0.00116	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000348	0.00116	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000346	0.00115	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000341	0.00113	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.00034	0.00113	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000338	0.00113	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000329	0.0011	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000327	0.00109	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000327	0.00109	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000326	0.00109	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000324	0.00108	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000324	0.00108	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000323	0.00108	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000323	0.00108	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000319	0.00106	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000316	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000315	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000315	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000314	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000314	0.00105	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000314	0.00105	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000313	0.00104	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.00031	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000309	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000307	0.00102	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000306	0.00102	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000299	0.000997	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000299	0.000996	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000299	0.000995	CbGpPWpGaD
Goserelin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000298	0.000437	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000298	0.000992	CbGpPWpGaD
Goserelin—Infection—Metformin—type 2 diabetes mellitus	0.000298	0.000436	CcSEcCtD
Goserelin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000297	0.000436	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000296	0.000434	CcSEcCtD
Goserelin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000295	0.000433	CcSEcCtD
Goserelin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000295	0.000432	CcSEcCtD
Goserelin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000295	0.000432	CcSEcCtD
Goserelin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000295	0.000432	CcSEcCtD
Goserelin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000295	0.000432	CcSEcCtD
Goserelin—Shock—Metformin—type 2 diabetes mellitus	0.000295	0.000432	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000294	0.00098	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000294	0.00098	CbGpPWpGaD
Goserelin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000294	0.000431	CcSEcCtD
Goserelin—Malaise—Losartan—type 2 diabetes mellitus	0.000294	0.000431	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000294	0.000979	CbGpPWpGaD
Goserelin—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000294	0.00043	CcSEcCtD
Goserelin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000294	0.00043	CcSEcCtD
Goserelin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000294	0.00043	CcSEcCtD
Goserelin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000293	0.00043	CcSEcCtD
Goserelin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000293	0.00043	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000293	0.000429	CcSEcCtD
Goserelin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000293	0.000429	CcSEcCtD
Goserelin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000292	0.000428	CcSEcCtD
Goserelin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000292	0.000428	CcSEcCtD
Goserelin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000292	0.000427	CcSEcCtD
Goserelin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000291	0.000427	CcSEcCtD
Goserelin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000291	0.000426	CcSEcCtD
Goserelin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00029	0.000425	CcSEcCtD
Goserelin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00029	0.000424	CcSEcCtD
Goserelin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00029	0.000424	CcSEcCtD
Goserelin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000288	0.000422	CcSEcCtD
Goserelin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000288	0.000422	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000288	0.000959	CbGpPWpGaD
Goserelin—Palpitations—Losartan—type 2 diabetes mellitus	0.000288	0.000422	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000288	0.000957	CbGpPWpGaD
Goserelin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000287	0.000421	CcSEcCtD
Goserelin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000287	0.00042	CcSEcCtD
Goserelin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000286	0.000419	CcSEcCtD
Goserelin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000286	0.000419	CcSEcCtD
Goserelin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000286	0.000419	CcSEcCtD
Goserelin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000286	0.000419	CcSEcCtD
Goserelin—Anorexia—Metformin—type 2 diabetes mellitus	0.000286	0.000418	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000285	0.00095	CbGpPWpGaD
Goserelin—Cough—Losartan—type 2 diabetes mellitus	0.000284	0.000417	CcSEcCtD
Goserelin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000284	0.000417	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000284	0.000945	CbGpPWpGaD
Goserelin—Alopecia—Ramipril—type 2 diabetes mellitus	0.000284	0.000416	CcSEcCtD
Goserelin—Fatigue—Valsartan—type 2 diabetes mellitus	0.000284	0.000415	CcSEcCtD
Goserelin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000283	0.000415	CcSEcCtD
Goserelin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000283	0.000415	CcSEcCtD
Goserelin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000283	0.000414	CcSEcCtD
Goserelin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000283	0.000414	CcSEcCtD
Goserelin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000283	0.000414	CcSEcCtD
Goserelin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000282	0.000413	CcSEcCtD
Goserelin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000281	0.000412	CcSEcCtD
Goserelin—Constipation—Valsartan—type 2 diabetes mellitus	0.000281	0.000412	CcSEcCtD
Goserelin—Infection—Irbesartan—type 2 diabetes mellitus	0.000281	0.000411	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000281	0.000935	CbGpPWpGaD
Goserelin—Fatigue—Orlistat—type 2 diabetes mellitus	0.00028	0.00041	CcSEcCtD
Goserelin—Hypotension—Metformin—type 2 diabetes mellitus	0.00028	0.00041	CcSEcCtD
Goserelin—Erythema—Ramipril—type 2 diabetes mellitus	0.000279	0.000409	CcSEcCtD
Goserelin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000279	0.000409	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000279	0.000929	CbGpPWpGaD
Goserelin—Shock—Irbesartan—type 2 diabetes mellitus	0.000278	0.000407	CcSEcCtD
Goserelin—Pain—Orlistat—type 2 diabetes mellitus	0.000278	0.000407	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000278	0.000924	CbGpPWpGaD
Goserelin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000277	0.000407	CcSEcCtD
Goserelin—Myalgia—Losartan—type 2 diabetes mellitus	0.000277	0.000407	CcSEcCtD
Goserelin—Chest pain—Losartan—type 2 diabetes mellitus	0.000277	0.000407	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000277	0.000923	CbGpPWpGaD
Goserelin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000277	0.000406	CcSEcCtD
Goserelin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000277	0.000406	CcSEcCtD
Goserelin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000277	0.000405	CcSEcCtD
Goserelin—Anxiety—Losartan—type 2 diabetes mellitus	0.000277	0.000405	CcSEcCtD
Goserelin—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000276	0.000404	CcSEcCtD
Goserelin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000275	0.000403	CcSEcCtD
Goserelin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000275	0.000402	CcSEcCtD
Goserelin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000275	0.000402	CcSEcCtD
Goserelin—Tension—Ramipril—type 2 diabetes mellitus	0.000274	0.000402	CcSEcCtD
Goserelin—Discomfort—Losartan—type 2 diabetes mellitus	0.000274	0.000402	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000274	0.000911	CbGpPWpGaD
Goserelin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000273	0.0004	CcSEcCtD
Goserelin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000273	0.0004	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000273	0.00091	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000273	0.00091	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000273	0.0004	CcSEcCtD
Goserelin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000273	0.0004	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000272	0.000907	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000272	0.000907	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000272	0.000906	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000272	0.000905	CbGpPWpGaD
Goserelin—Nervousness—Ramipril—type 2 diabetes mellitus	0.000271	0.000398	CcSEcCtD
Goserelin—Dry mouth—Losartan—type 2 diabetes mellitus	0.000271	0.000398	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000271	0.000902	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000271	0.000901	CbGpPWpGaD
Goserelin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000269	0.000395	CcSEcCtD
Goserelin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000269	0.000394	CcSEcCtD
Goserelin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000269	0.000394	CcSEcCtD
Goserelin—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000269	0.000394	CcSEcCtD
Goserelin—Confusional state—Losartan—type 2 diabetes mellitus	0.000268	0.000393	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000268	0.000892	CbGpPWpGaD
Goserelin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000268	0.000392	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000267	0.00089	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000267	0.00089	CbGpPWpGaD
Goserelin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000267	0.000391	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000267	0.000888	CbGpPWpGaD
Goserelin—Somnolence—Metformin—type 2 diabetes mellitus	0.000266	0.00039	CcSEcCtD
Goserelin—Oedema—Losartan—type 2 diabetes mellitus	0.000266	0.00039	CcSEcCtD
Goserelin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000266	0.00039	CcSEcCtD
Goserelin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000266	0.000389	CcSEcCtD
Goserelin—Infection—Losartan—type 2 diabetes mellitus	0.000264	0.000387	CcSEcCtD
Goserelin—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000264	0.000387	CcSEcCtD
Goserelin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000264	0.000386	CcSEcCtD
Goserelin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000264	0.000386	CcSEcCtD
Goserelin—Shock—Losartan—type 2 diabetes mellitus	0.000262	0.000383	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000262	0.000871	CbGpPWpGaD
Goserelin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000261	0.000383	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000261	0.000869	CbGpPWpGaD
Goserelin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000261	0.000382	CcSEcCtD
Goserelin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00026	0.000382	CcSEcCtD
Goserelin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00026	0.000381	CcSEcCtD
Goserelin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00026	0.000381	CcSEcCtD
Goserelin—Tachycardia—Losartan—type 2 diabetes mellitus	0.00026	0.00038	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000259	0.000864	CbGpPWpGaD
Goserelin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000259	0.00038	CcSEcCtD
Goserelin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00038	CcSEcCtD
Goserelin—Fatigue—Metformin—type 2 diabetes mellitus	0.000258	0.000378	CcSEcCtD
Goserelin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000258	0.000378	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000258	0.000377	CcSEcCtD
Goserelin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000257	0.000377	CcSEcCtD
Goserelin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000257	0.000376	CcSEcCtD
Goserelin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000257	0.000376	CcSEcCtD
Goserelin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000257	0.000376	CcSEcCtD
Goserelin—Constipation—Metformin—type 2 diabetes mellitus	0.000256	0.000375	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000254	0.000847	CbGpPWpGaD
Goserelin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000254	0.000372	CcSEcCtD
Goserelin—Anorexia—Losartan—type 2 diabetes mellitus	0.000254	0.000371	CcSEcCtD
Goserelin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000253	0.000371	CcSEcCtD
Goserelin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000253	0.000371	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000252	0.000841	CbGpPWpGaD
Goserelin—Malaise—Ramipril—type 2 diabetes mellitus	0.000252	0.000369	CcSEcCtD
Goserelin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000252	0.000369	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000252	0.000838	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000252	0.000838	CbGpPWpGaD
Goserelin—Rash—Glyburide—type 2 diabetes mellitus	0.000251	0.000368	CcSEcCtD
Goserelin—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000251	0.000368	CcSEcCtD
Goserelin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000251	0.000368	CcSEcCtD
Goserelin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00025	0.000366	CcSEcCtD
Goserelin—Headache—Glyburide—type 2 diabetes mellitus	0.00025	0.000366	CcSEcCtD
Goserelin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000249	0.000365	CcSEcCtD
Goserelin—Hypotension—Losartan—type 2 diabetes mellitus	0.000249	0.000364	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000248	0.000826	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000247	0.000824	CbGpPWpGaD
Goserelin—Palpitations—Ramipril—type 2 diabetes mellitus	0.000247	0.000362	CcSEcCtD
Goserelin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000247	0.000362	CcSEcCtD
Goserelin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000246	0.00036	CcSEcCtD
Goserelin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000245	0.000359	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000245	0.000816	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000245	0.000816	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000245	0.000359	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000244	0.000812	CbGpPWpGaD
Goserelin—Cough—Ramipril—type 2 diabetes mellitus	0.000244	0.000357	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000244	0.000812	CbGpPWpGaD
Goserelin—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000244	0.000357	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000243	0.00081	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000242	0.000355	CcSEcCtD
Goserelin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000242	0.000355	CcSEcCtD
Goserelin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000242	0.000355	CcSEcCtD
Goserelin—Pain—Irbesartan—type 2 diabetes mellitus	0.000242	0.000354	CcSEcCtD
Goserelin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000242	0.000354	CcSEcCtD
Goserelin—Insomnia—Losartan—type 2 diabetes mellitus	0.000241	0.000352	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.00024	0.000798	CbGpPWpGaD
Goserelin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000239	0.000351	CcSEcCtD
Goserelin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000239	0.00035	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000239	0.000795	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000239	0.000795	CbGpPWpGaD
Goserelin—Urticaria—Metformin—type 2 diabetes mellitus	0.000238	0.000349	CcSEcCtD
Goserelin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000238	0.000349	CcSEcCtD
Goserelin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000238	0.000349	CcSEcCtD
Goserelin—Myalgia—Ramipril—type 2 diabetes mellitus	0.000238	0.000349	CcSEcCtD
Goserelin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000237	0.000347	CcSEcCtD
Goserelin—Anxiety—Ramipril—type 2 diabetes mellitus	0.000237	0.000347	CcSEcCtD
Goserelin—Nausea—Glyburide—type 2 diabetes mellitus	0.000237	0.000347	CcSEcCtD
Goserelin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000237	0.000347	CcSEcCtD
Goserelin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000237	0.000347	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000237	0.000788	CbGpPWpGaD
Goserelin—Somnolence—Losartan—type 2 diabetes mellitus	0.000236	0.000346	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000236	0.000346	CcSEcCtD
Goserelin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000236	0.000346	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000236	0.000785	CbGpPWpGaD
Goserelin—Discomfort—Ramipril—type 2 diabetes mellitus	0.000235	0.000344	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000235	0.000782	CbGpPWpGaD
Goserelin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000234	0.000343	CcSEcCtD
Goserelin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000233	0.000342	CcSEcCtD
Goserelin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000233	0.000341	CcSEcCtD
Goserelin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000233	0.000341	CcSEcCtD
Goserelin—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000233	0.000341	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000232	0.000771	CbGpPWpGaD
Goserelin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000231	0.000339	CcSEcCtD
Goserelin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000231	0.000339	CcSEcCtD
Goserelin—Confusional state—Ramipril—type 2 diabetes mellitus	0.00023	0.000337	CcSEcCtD
Goserelin—Pruritus—Orlistat—type 2 diabetes mellitus	0.00023	0.000337	CcSEcCtD
Goserelin—Fatigue—Losartan—type 2 diabetes mellitus	0.000229	0.000336	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000229	0.000763	CbGpPWpGaD
Goserelin—Oedema—Ramipril—type 2 diabetes mellitus	0.000228	0.000334	CcSEcCtD
Goserelin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000228	0.000334	CcSEcCtD
Goserelin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000228	0.000333	CcSEcCtD
Goserelin—Pain—Losartan—type 2 diabetes mellitus	0.000227	0.000333	CcSEcCtD
Goserelin—Constipation—Losartan—type 2 diabetes mellitus	0.000227	0.000333	CcSEcCtD
Goserelin—Rash—Gliclazide—type 2 diabetes mellitus	0.000226	0.000331	CcSEcCtD
Goserelin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000226	0.00033	CcSEcCtD
Goserelin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000225	0.00033	CcSEcCtD
Goserelin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000225	0.000329	CcSEcCtD
Goserelin—Shock—Ramipril—type 2 diabetes mellitus	0.000224	0.000329	CcSEcCtD
Goserelin—Headache—Gliclazide—type 2 diabetes mellitus	0.000224	0.000329	CcSEcCtD
Goserelin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000224	0.000328	CcSEcCtD
Goserelin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000223	0.000327	CcSEcCtD
Goserelin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000223	0.000327	CcSEcCtD
Goserelin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000223	0.000327	CcSEcCtD
Goserelin—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000223	0.000326	CcSEcCtD
Goserelin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000222	0.000326	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000222	0.000739	CbGpPWpGaD
Goserelin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000222	0.000325	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000221	0.000736	CbGpPWpGaD
Goserelin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000221	0.000323	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00022	0.000734	CbGpPWpGaD
Goserelin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000219	0.000321	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000218	0.000727	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000218	0.000727	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000218	0.000727	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000218	0.000319	CcSEcCtD
Goserelin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000218	0.000319	CcSEcCtD
Goserelin—Anorexia—Ramipril—type 2 diabetes mellitus	0.000217	0.000319	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000216	0.00072	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000216	0.00072	CbGpPWpGaD
Goserelin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000215	0.000315	CcSEcCtD
Goserelin—Asthenia—Metformin—type 2 diabetes mellitus	0.000215	0.000315	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000215	0.000715	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000214	0.000713	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000213	0.00071	CbGpPWpGaD
Goserelin—Hypotension—Ramipril—type 2 diabetes mellitus	0.000213	0.000312	CcSEcCtD
Goserelin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000213	0.000312	CcSEcCtD
Goserelin—Pruritus—Metformin—type 2 diabetes mellitus	0.000212	0.00031	CcSEcCtD
Goserelin—Urticaria—Losartan—type 2 diabetes mellitus	0.000211	0.00031	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000211	0.000702	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000211	0.000702	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.00021	0.0007	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.00021	0.0007	CbGpPWpGaD
Goserelin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00021	0.000308	CcSEcCtD
Goserelin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00021	0.000308	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.00021	0.000699	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000209	0.000697	CbGpPWpGaD
Goserelin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000209	0.000306	CcSEcCtD
Goserelin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000208	0.000305	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000208	0.000304	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000207	0.000691	CbGpPWpGaD
Goserelin—Rash—Valsartan—type 2 diabetes mellitus	0.000207	0.000304	CcSEcCtD
Goserelin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000207	0.000304	CcSEcCtD
Goserelin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000207	0.000303	CcSEcCtD
Goserelin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000206	0.000302	CcSEcCtD
Goserelin—Headache—Valsartan—type 2 diabetes mellitus	0.000206	0.000302	CcSEcCtD
Goserelin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000205	0.0003	CcSEcCtD
Goserelin—Rash—Orlistat—type 2 diabetes mellitus	0.000205	0.0003	CcSEcCtD
Goserelin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000205	0.0003	CcSEcCtD
Goserelin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000205	0.0003	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000204	0.00068	CbGpPWpGaD
Goserelin—Headache—Orlistat—type 2 diabetes mellitus	0.000204	0.000298	CcSEcCtD
Goserelin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000203	0.000298	CcSEcCtD
Goserelin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000203	0.000297	CcSEcCtD
Goserelin—Somnolence—Ramipril—type 2 diabetes mellitus	0.000203	0.000297	CcSEcCtD
Goserelin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000201	0.000294	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000201	0.000668	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000201	0.000668	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.0002	0.000666	CbGpPWpGaD
Goserelin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.0002	0.000293	CcSEcCtD
Goserelin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000198	0.00029	CcSEcCtD
Goserelin—Dizziness—Metformin—type 2 diabetes mellitus	0.000198	0.00029	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000197	0.000656	CbGpPWpGaD
Goserelin—Fatigue—Ramipril—type 2 diabetes mellitus	0.000197	0.000288	CcSEcCtD
Goserelin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000196	0.000287	CcSEcCtD
Goserelin—Nausea—Valsartan—type 2 diabetes mellitus	0.000195	0.000286	CcSEcCtD
Goserelin—Constipation—Ramipril—type 2 diabetes mellitus	0.000195	0.000286	CcSEcCtD
Goserelin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000193	0.000283	CcSEcCtD
Goserelin—Nausea—Orlistat—type 2 diabetes mellitus	0.000193	0.000283	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000192	0.000641	CbGpPWpGaD
Goserelin—Asthenia—Losartan—type 2 diabetes mellitus	0.000191	0.00028	CcSEcCtD
Goserelin—Vomiting—Metformin—type 2 diabetes mellitus	0.00019	0.000279	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00019	0.000633	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.00019	0.000632	CbGpPWpGaD
Goserelin—Rash—Metformin—type 2 diabetes mellitus	0.000189	0.000277	CcSEcCtD
Goserelin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000189	0.000276	CcSEcCtD
Goserelin—Pruritus—Losartan—type 2 diabetes mellitus	0.000188	0.000276	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000188	0.000627	CbGpPWpGaD
Goserelin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000188	0.000275	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000188	0.000626	CbGpPWpGaD
Goserelin—Headache—Metformin—type 2 diabetes mellitus	0.000188	0.000275	CcSEcCtD
Goserelin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000187	0.000274	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000187	0.000622	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000187	0.000273	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000186	0.000618	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000186	0.000618	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000186	0.000618	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000185	0.000615	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000184	0.000613	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000183	0.000609	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000182	0.000607	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000182	0.000607	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000182	0.000606	CbGpPWpGaD
Goserelin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000182	0.000267	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000181	0.000604	CbGpPWpGaD
Goserelin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000181	0.000265	CcSEcCtD
Goserelin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00018	0.000264	CcSEcCtD
Goserelin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00018	0.000264	CcSEcCtD
Goserelin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00018	0.000263	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000179	0.000597	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000179	0.000596	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000179	0.000595	CbGpPWpGaD
Goserelin—Rash—Irbesartan—type 2 diabetes mellitus	0.000178	0.000261	CcSEcCtD
Goserelin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000178	0.000261	CcSEcCtD
Goserelin—Nausea—Metformin—type 2 diabetes mellitus	0.000178	0.000261	CcSEcCtD
Goserelin—Headache—Irbesartan—type 2 diabetes mellitus	0.000177	0.000259	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000177	0.000588	CbGpPWpGaD
Goserelin—Dizziness—Losartan—type 2 diabetes mellitus	0.000176	0.000258	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000175	0.000582	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000174	0.000578	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000171	0.00057	CbGpPWpGaD
Goserelin—Vomiting—Losartan—type 2 diabetes mellitus	0.000169	0.000248	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000169	0.000563	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000169	0.000561	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000169	0.000561	CbGpPWpGaD
Goserelin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000168	0.000246	CcSEcCtD
Goserelin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000168	0.000246	CcSEcCtD
Goserelin—Rash—Losartan—type 2 diabetes mellitus	0.000168	0.000246	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000168	0.000558	CbGpPWpGaD
Goserelin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000168	0.000245	CcSEcCtD
Goserelin—Headache—Losartan—type 2 diabetes mellitus	0.000167	0.000244	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000166	0.000553	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000164	0.000546	CbGpPWpGaD
Goserelin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000164	0.00024	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000163	0.000544	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000163	0.000544	CbGpPWpGaD
Goserelin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000161	0.000236	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000161	0.000535	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.00016	0.000534	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.00016	0.000532	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.00016	0.000532	CbGpPWpGaD
Goserelin—Nausea—Losartan—type 2 diabetes mellitus	0.000158	0.000231	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000158	0.000526	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000158	0.000526	CbGpPWpGaD
Goserelin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000156	0.000229	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—C3—type 2 diabetes mellitus	0.000154	0.000514	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000153	0.000511	CbGpPWpGaD
Goserelin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000151	0.000221	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000149	0.000495	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000148	0.000493	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000147	0.00049	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000147	0.000489	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000147	0.000488	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000146	0.000487	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000146	0.000487	CbGpPWpGaD
Goserelin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000145	0.000212	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000144	0.00048	CbGpPWpGaD
Goserelin—Rash—Ramipril—type 2 diabetes mellitus	0.000144	0.000211	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000144	0.000479	CbGpPWpGaD
Goserelin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000144	0.00021	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000144	0.000478	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000144	0.000478	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000143	0.000477	CbGpPWpGaD
Goserelin—Headache—Ramipril—type 2 diabetes mellitus	0.000143	0.000209	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000142	0.000473	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000137	0.000455	CbGpPWpGaD
Goserelin—Nausea—Ramipril—type 2 diabetes mellitus	0.000135	0.000198	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000135	0.000451	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000134	0.000447	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000134	0.000447	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000128	0.000427	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000127	0.000423	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000126	0.000419	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000124	0.000414	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000124	0.000414	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000124	0.000412	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000123	0.00041	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INS—type 2 diabetes mellitus	0.000123	0.000408	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000122	0.000406	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000121	0.000402	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOB—type 2 diabetes mellitus	0.00012	0.0004	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.00012	0.000398	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000119	0.000395	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000119	0.000395	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000118	0.000394	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000118	0.000393	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000115	0.000382	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000113	0.000375	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000112	0.000374	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000108	0.000358	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000108	0.000358	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000108	0.000358	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000106	0.000352	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—C3—type 2 diabetes mellitus	0.000103	0.000344	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000101	0.000337	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.85e-05	0.000328	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.82e-05	0.000327	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—type 2 diabetes mellitus	9.81e-05	0.000327	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.65e-05	0.000321	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—type 2 diabetes mellitus	9.61e-05	0.00032	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—type 2 diabetes mellitus	9.61e-05	0.00032	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.5e-05	0.000316	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.22e-05	0.000307	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.13e-05	0.000304	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.07e-05	0.000302	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.07e-05	0.000302	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.63e-05	0.000287	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.58e-05	0.000286	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.54e-05	0.000284	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.37e-05	0.000279	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INS—type 2 diabetes mellitus	8.21e-05	0.000273	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.08e-05	0.000269	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SRC—type 2 diabetes mellitus	7.96e-05	0.000265	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.94e-05	0.000265	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.94e-05	0.000264	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.9e-05	0.000263	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.75e-05	0.000258	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.54e-05	0.000251	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.2e-05	0.00024	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.2e-05	0.00024	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.11e-05	0.000237	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.98e-05	0.000232	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RELA—type 2 diabetes mellitus	6.78e-05	0.000226	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.17e-05	0.000205	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.11e-05	0.000204	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.07e-05	0.000202	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.78e-05	0.000192	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.72e-05	0.00019	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.6e-05	0.000187	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—type 2 diabetes mellitus	5.36e-05	0.000178	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SRC—type 2 diabetes mellitus	5.33e-05	0.000177	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.19e-05	0.000173	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.95e-05	0.000165	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.76e-05	0.000159	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.67e-05	0.000155	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—type 2 diabetes mellitus	3.59e-05	0.000119	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.31e-05	0.00011	CbGpPWpGaD
